Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors

American Journal of Pathology

Volumn 156, Issue 6, 2000, Pages 2135-2147

  Noguchi, Takashi ^a   Dobashi, Yoh ^a   Minehara, Hiroaki ^a   Itoman, Moritoshi ^a   Kameya, Toru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN E; CYCLINE; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LEIOMYOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SOFT TISSUE TUMOR;

EID: 0033887909     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65084-5     Document Type: Article

References (52)

1. Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical, and electron microscopic study
2. Cutaneous and subcutaneous leiomyosarcoma. A clinicopathologic study of 47 patients
3. Smooth muscle tumor of the gastrointestinal tract and retroperitoneum
4. Leiomyosarcoma of soft tissue: A clinicopathologic study
5. Retroperitoneal leiomyosarcoma: A clinicopathologic analysis of 36 cases
6. Soft tissue leiomyosarcoma. A population-based epidemiological and prognostic study of 48 patients, including cellular DNA content
7. Leiomyosarcoma of the skin and subcutaneous tissue
8. Leiomyoma of deep soft tissue. Clinicopathologic analysis of a series
9. The difficulty in predicting behavior of smooth-muscle tumors in deep soft tissue
10. Cutaneous pilar leiomyoma: Clinicopathologic analysis of 53 lesions in 45 patients
11. Recurrent cutaneous leiomyosarcoma
12. Abnormality of the p53, MDM2 and DCC genes in human leiomyosarcomss
13. Tumor suppressor genes and related molecules in leiomyosarcoma
14. Leiomyosarcoma in soft tissue: Examination of p53 status and cell proliferating factors in different locations
15. Human D-type cyclin
16. Cyclin E/cdk2 and cyclin A/cdk2 kinase associated with p107 and E2F in a temporary distinct manner
17. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: Accumulation of inactive cyclin E-cdk2 and cyclin D1-cdk2 complexes
18. Association of human cyclin E with a periodic G1-S phase protein kinase
19. G1 phase progression: Cycling on cue
20. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age
21. Cancer cell cycle
22. A novel cyclin associated with MO15/CDK7 to form the CDK-activating kinase
23. A cyclin associated with the CDK-activating kinase MO15
24. Cell cycle analysis of the activity, subcellular localization and subunit composition of human CAK (CDK-activating kinase)
25. Principles of CDK regulation
26. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
27. p21 is a universal inhibitor of cyclin kinases
28. Cloning of P57(KIP2), a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
29. p57(KIP2), a structurally distinct member of the p21 cdk inhibitor family, is a candidate tumor suppressor gene
30. Cutaneous leiomyosarcoma
31. Primary leiomyosarcoma of bone: A clinicopathologic, immunohistochemical, and ultrastructural study of 33 patients and a literature review
32. Active cyclin A-cdk2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas
33. Mode of tumor extension and cell proliferation in adenocarcinomas of the lung
34. Constitutive overexpression of cdk2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells
35. D-type cyclin dependent kinase activity in mammalian cells
36. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA
37. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinoma using the novel 'paraffin'-reactive MIB-1 antibody
38. Alternative splicing of human cyclin E
39. Immunohistochemistry (Ki-67 and p53) as a tool in determining malignancy in smooth muscle neoplasms (exemplified by a myxoid leiomyosarcoma of the uterus)
40. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
41. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma
42. Genetic alteration in human gastrointestinal cancers. The application to molecular diagnosis
43. Deregulation of cyclin E in breast cancer
44. A variant form of cyclin-dependent kinase 2 (Cdk2) in a malignantly transformed rat thyroid (FRTL-Tc) cell line
45. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness
46. Cyclin E, a potential prognostic marker for breast carcinoma
47. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma
48. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma
49. Concurrent amplification of cyclin E and cdk2 genes in colorectal carcinomas
50. Analysis of cyclin E and cdk2 in ovarian cancer: Gene amplification and RNA overexpression
51. Altered expression of cyclin D1 and cdk4 genes in ovarian carcinomas
52. Expression of cell cycle regulatory factors in differentiating osteoblasts: Postproliferative up-regulation of cyclin B and E